OSE Immunotherapeutics Announces Issuance of a New Patent in Japan for Tedopi® on Inducing Early T-Lymphocyte Memory Response

by NASDAQ Market News January 14, 2020

NASDAQ Market News
Click here to email author

Astellas and Adaptimmune Enter into Agreement to Co-Develop and Co-Commercialize Stem-Cell Derived Allogeneic CAR-T and TCR T-Cell Therapies

Curetis Launches Unyvero LRT Panel for BAL Specimens in the U.S.

Ads